An open-label cluster-randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19 (ARCHAIC)-Protocol publication
Publication date
2020-07
Authors
Weehuizen, Jesper M
Hoepelman, Andy
Editors
Advisors
Supervisors
Document Type
Editorial
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Antiviral Agents/therapeutic use, Betacoronavirus, COVID-19, Chloroquine/therapeutic use, Coronavirus Infections/drug therapy, Electrocardiography, Hospitalization, Humans, Hydroxychloroquine/therapeutic use, Long QT Syndrome/chemically induced, Netherlands, Pandemics, Pneumonia, Viral/drug therapy, SARS-CoV-2, Severity of Illness Index, Treatment Outcome, Taverne, Biochemistry, Clinical Biochemistry, Editorial, Randomized Controlled Trial
Citation
Weehuizen, J M & Hoepelman, A I M 2020, 'An open-label cluster-randomized controlled trial of chloroquine, hydroxychloroquine or only supportive care in patients admitted with moderate to severe COVID-19 (ARCHAIC)-Protocol publication', European Journal of Clinical Investigation, vol. 50, no. 7, e13297. https://doi.org/10.1111/eci.13297